3 recruiting, 2 completed, 1 active not recruiting, 1 unknown. 3 Phase 2, 2 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 3 | Active not recruiting 1, Completed 1, Recruiting 1 |
| Phase 1 | 2 | Completed 2 |
Follow Locally Advanced Lung Carcinoma: new trials by email Literature Review of Locally Advanced Lung Carcinoma trials Research Report on Locally Advanced Lung Carcinoma
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Cadonilimab(AK104) Plus Concurrent Chemoradiotherapy in Patients With Locally Advanced, Unresectable, Stage III NSCLC Cadonilimab (AK104) - NSCLC, Locally Advanced Lung Carcinoma | Phase 2 | Active not recruiting | Fudan University | 41 | 2024-07-01 | 2025-09-24 |
| Esomeprazole and Radiation Induced Esophagitis Esomeprazole 40 mg - Radiation Esophagitis, Locally Advanced Lung Carcinoma | Phase 2 | Recruiting | Rush University Medical Center | 48 | 2024-03-01 | 2026-08-14 |
| ProCaLung: Project on Cancer of the Lung Locally Advanced Lung Carcinoma | Unknown | Jules Bordet Institute | 1000 | 2021-10-01 | 2023-06-12 | |
| Fraction Dose Escalation of Hypo-fractionated Radiotherapy in LANSCLC Hypofractionated radiotherapy, Concurrent chemotherapy, Consolidation immunotherapy - Locally Advanced Lung Carcinoma | Phase 1 | Completed | Sun Yat-sen University | 18 | 2021-06-01 | 2023-12-15 |
| Using Microbiome to Predict Durvalumab Toxicity in Post- Concurrent Chemoradiation Therapy (CCRT) NSCLC Patients NSCLC, Stage III, Locally Advanced Lung Carcinoma | Recruiting | Jun Zhang, MD, PhD | 44 | 2021-04-12 | 2024-05-08 | |
| Endobronchial Ultrasound Guided Interstitial Photodynamic Therapy in Treating Patients With Locally Advanced Lung Cancer Porfimer Sodium, Ultrasound-Guided Transbronchial Needle-Delivered Interstitial Photodynamic Therapy - Locally Advanced Lung Carcinoma, Non-Small Cell Lung Carcinoma | Phase 1 / Phase 2 | Completed | Roswell Park Cancer Institute | 19 | 2020-02-12 | 2026-05-14 |
| Evaluation of Anti-PD-1 Therapy by Monitoring T Cell Responses in Melanoma, Lung and Other Cancer Types Biospecimen Collection, Electronic Health Record Review - Clinical Stage III Cutaneous Melanoma AJCC v8, Clinical Stage IV Cutaneous Melanoma AJCC v8 | Recruiting | Mayo Clinic | 500 | 2015-06-15 | 2026-06-18 |
Carcinoma, Non-Small-Cell Lung (2) · Lung Neoplasms (2) · Melanoma (1) · Neoplasm Metastasis (1) · Small Cell Lung Carcinoma (1)
Lung Diseases (3) · Neoplasms (3) · Neoplasms by Site (3) · Respiratory Tract Diseases (3) · Respiratory Tract Neoplasms (3) · Thoracic Neoplasms (3) · Bronchial Neoplasms (2) · Carcinoma, Bronchogenic (2) · Lung Neoplasms (1) · Neoplasms by Histologic Type (1) · Neoplasms, Germ Cell and Embryonal (1) · Neoplasms, Nerve Tissue (1) · Neoplastic Processes (1) · Neuroectodermal Tumors (1) · Neuroendocrine Tumors (1)
Chemoradiotherapy (1) · Dihematoporphyrin Ether (1) · Esomeprazole (1) · Radiation Dose Hypofractionation (1) · Specimen Handling (1)
Fudan University (1) · Jules Bordet Institute (1) · Jun Zhang, MD, PhD (1) · Mayo Clinic (1) · Roswell Park Cancer Institute (1) · Rush University Medical Center (1) · Sun Yat-sen University (1)
United States (4) · China (2) · Belgium (1)
Hui Liu, Professor (1) · Jun Zhang, MD, PhD (1) · Luigi Moretti, MD, PhD (1) · Nathaniel Ivanick, MD (1) · Soumyajit M Roy, PhD (1) · Svetomir N. Markovic, MD, PhD (1)
F30CA250326 (1), R21CA197878 (1), R44CA265656 (1)